Sign In | Administration | Contact us
Our People
Clinical Professor Graeme Stewart AM

T +61 2 9845 6791

F +61 2 9891 3889



Professor Graeme Stewart AM

Professor Graeme Stewart AM is both a consultant physician and pathologist in the field of immunology.

He is the founding head of the Department of Clinical Immunology and Allergy at Westmead Hospital and founding director of the Institute for Immunology and Allergy Research (IIAR), one of the four founding research groups of the Westmead Millennium Institute.

Professor Stewart’s research interests focus on the immunogenetics of human disease particularly multiple sclerosis, HIV/AIDS, Hepatitis C and allergic disorders.

The goal of this research is to better understand the mechanisms by which genetic factors influence the immune system in causing these disease states, in the severity and progression of disease and in response to therapy with the ultimate aim of assisting the development of new approaches to more effective treatment or prevention.

- 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 -


  • The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Nat Genet. 2009 Jun 14. [Epub ahead of print]
  • Stewart G. Multiple sclerosis and vitamin D: don't (yet) blame it on the sunshine. Brain. 2009 May;132(Pt 5):1126-7. [Abstract]
  • Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ; ANZgene Consortium, Kilpatrick TJ, Rubio JP. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens. 2009 Jul;74(1):17-21. [Abstract]
  • Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, Hawkins C, Robertson NP, Dudbridge F, Wason J, De Jager PL, Hafler D, Rioux JD, Ivinson AJ, McCauley JL, Pericak-Vance M, Oksenberg JR, Hauser SL, Sexton D, Haines J, Sawcer S. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur J Hum Genet. 2009 Mar 18. [Epub ahead of print]
  • De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, Pobywajlo S, Rossin E, Hu X, Ashley CW, Choy E, Rioux JD, Pericak-Vance MA, Ivinson A, Booth DR, Stewart GJ, Palotie A, Peltonen L, Dubois B, Haines JL, Weiner HL, Compston A, Hauser SL, Daly MJ, Reich D, Oksenberg JR, Hafler DA. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A. 2009 Mar 31;106 (13): 5264-9. [Abstract]
  • Stewart GJ, Dwyer JM. Implementation of the Garling recommendations can offer real hope for rescuing the New South Wales public hospital system. Med J Aust. 2009 Jan 19;190(2):80-2. [Abstract]
  • International Multiple Sclerosis Genetics Consortium (IMSGC). The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun. 2009 Jan;10(1):11-4 [Abstract]


  • Horton, P., Hawthorne, W., Walters, S., Patel, T., Stewart, G., Allen, R., Chapman, J. Tolerance induction in a large-animal model using total lymphoid irradiation and intrathymic bone marrow. Transplantation. 2008; 86:1830-1836. [Abstract]
  • Gandhi, K., McKay, F., Schibeci, S., Arthur, J., Heard, R., Stewart, G., Booth, D. BAFF is a Biological Response Marker to IFN-beta Treatment in Multiple Sclerosis. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2008; 28:529-39. [Abstract]
  • Lee, C., Gala, S., Stewart, G., Williamson, P. The Proline-Rich Region of HIV-1 Nef Affects CXCR4-Mediated Chemotaxis in Jurkat T Cells. Viral immunology. 2008; 21:347-54. [Abstract]
  • McKay, F., Swain, L., Schibeci, S., Rubio, J., Kilpatrick, T., Heard, R., Stewart, G., Booth, D. CD127 immunophenotyping suggests altered CD4(+) T cell regulation in primary progressive multiple sclerosis. Journal of autoimmunity. 2008; 31:52-58. [Abstract]
  • Clarke, E., Rahman, N., Page, N., Rolph, M., Stewart, G., Jones, G. Functional characterization of the atopy-associated gene PHF11. The Journal of allergy and clinical immunology. 2008; 121:1148-1154.e3. [Abstract]
  • McKay, F., Swain, L., Schibeci, S., Rubio, J., Kilpatrick, T., Heard, R., Stewart, G., Booth, D. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes and immunity. 2008; 9:1-6. [Abstract]
  • Arthur, A., Armati, P., Bye, C., , S., Heard, R., Stewart, G., Pollard, J., Booth, D. Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Medical Genetics. 2008; 9:17. [Abstract]
  • Burfoot, R., Jensen, C., Field, J., Stankovich, J., Varney, M., Johnson, L., Butzkueven, H., Booth, D., Bahlo, M., Tait, B., Taylor, B., Speed, T., Heard, R., Stewart, G., Foote, S., Kilpatrick, T., Rubio, J. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue antigens. 2008; 71:42-50. [Abstract]




  • Hensiek, A., Seaman, S., Barcellos, L., Oturai, A., Eraksoi, M., Cocco, E., Vecsei, L., Stewart, G., Dubois, B., Bellman-Strobl, J., Leone, M., Andersen, O., Bencsik, K., Booth, D., Celius, E., Harbo, H., Hauser, S., Heard, R., Hillert, J., Myhr, K., Marrosu, M., Oksenberg, J., Rajda, C., Sawcer, S., Sørensen, P., Zipp, F., Compston, D. Familial effects on the clinical course of multiple sclerosis. Neurology. 2007; 68:376-383. [Abstract]
  • Gabutero, E., Moore, C., Mallal, S., Stewart, G., Williamson, P. Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDS. AIDS (London, England). 2007; 21:65-69. [Abstract]


  • Bugeja, M, Booth, D, Bennetts, B, Heard, R, Stewart, G. An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians. Multiple sclerosis (Houndmills, Basingstoke , England ). 2006; 12:710-22 [Abstract]
  • Stewart, G, Dwyer, J, Goulston, K. The Greater Metropolitan Clinical Taskforce: an Australian model for clinician governance. The Medical journal of Australia . 2006; 184:597-8 [Abstract]
  • McKay, F, Schibeci, S, Heard, R, Stewart, G, Booth, D. Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: a comparison of three methods in a large Australasian cohort. Journal of immunological methods. 2006; 310:20-9 [Abstract]
  • Jones, G, Wu, S, Jang, N, Fulcher, D, Hogan, P, Stewart, G. Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. The British journal of dermatology. 2006; 154:467-71 [Abstract]
  • Page, N, Jones, G, Stewart, G. Genetic Association Studies between the T Cell Immunoglobulin Mucin (TIM) Gene Locus and Childhood Atopic Dermatitis. International archives of allergy and immunology. 2006; 141:331-6 [Abstract]
  • Bugeja, M, Booth, D, Bennetts, B, Heard, R, Rubio, J, Stewart, G. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC medical genetics [electronic resource]. 2006; 7:64 [Abstract]


  • Booth, D, Arthur, A, Teutsch, S, Bye, C, Rubio, J, Armati, P, Pollard, J, Heard, R, Stewart, G, , T. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. Journal of molecular medicine ( Berlin , Germany ). 2005; 83:822-30 [Abstract]
  • Sawcer, S, Ban, M, Maranian, M, Yeo, T, Compston, A, Kirby, A, Daly, M, De Jager, P, Walsh, E, Lander, E, Rioux, J, Hafler, D, Ivinson, A, Rimmler, J, Gregory, S, Schmidt, S, Pericak-Vance, M, Akesson, E, Hillert, J, Datta, P, Oturai, A, Ryder, L, Harbo, H, Spurkland, A, Myhr, K, Laaksonen, M, Booth, D, Heard, R, Stewart, G, Lincoln, R, Barcellos, L, Hauser, S, Oksenberg, J, Kenealy, S, Haines, J, , I. A high-density screen for linkage in multiple sclerosis. American journal of human genetics. 2005; 77:454-67 [Abstract]
  • Bugeja, M, Booth, D, Bennetts, B, Heard, R, Burgner, D, Stewart, G. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. European journal of human genetics: EJHG. 2005; 13:815-22 [Abstract]
  • Jang, N, Stewart, G, Jones, G. Polymorphisms within the PHF11 gene at chromosome 13q14 are associated with childhood atopic dermatitis. Genes and immunity. 2005; 6:262-4 [Abstract]


  • Dao-Ung, L, Fuller, S, Sluyter, R, SkarRatt, K, Thunberg, U, Tobin, G, Byth, K, Ban, M, Rosenquist, R, Stewart, G, Wiley, J. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. British journal of haematology. 2004. p. 815-7. [Abstract]
  • Djordjevic, J, Schibeci, S, Stewart, G, Williamson, P. HIV type 1 Nef increases the association of T cell receptor (TCR)-signaling molecules with T cell rafts and promotes activation-induced raft fusion. AIDS research and human retroviruses. 2004; 20:547-55 [Abstract]
  • Bugeja, M, Booth, D, Bennetts, B, Guerin, J, Kaldor, J, Stewart, G, , A. Analysis of the CCL3-L1 gene for association with HIV-1 susceptibility and disease progression. AIDS ( London , England ). 2004; 18:1069-71 [Abstract]
  • Teutsch, S, Booth, D, Bennetts, B, Heard, R, Stewart, G. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. Journal of neuroimmunology. 2004; 148:218-30 [Abstract]
  • Jones, G, Stewart, G. Nuclear import of N-terminal FAK by activation of the FcepsilonRI receptor in RBL-2H3 cells. Biochemical and biophysical research communications. 2004; 314:39-45 [Abstract]


  • Keoshkerian, D, Ashton, L, Smith, D, Ziegler, J, Kaldor, J, Cooper, D, Stewart, G, Ffrench, R. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression. Journal Of Medical Virology. 2003; 71:483-491
  • Verran, D, Kusyk, T, Painter, D, Fisher, J, Koorey, D, Strasser, S, Stewart, G, McCaughan, G. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplantation. 2003; Vol 9, No. 5:500-505
  • Ban, M, Sawcer, S, Heard, R, Bennetts, B, Adams, S, Booth, D, Perich, V, Setakis, E, Compston, A, Stewart, G. A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients. Journal Of Neuroimmunology. 2003; 143:60-64
  • Teutsch, S, Booth, D, Bennetts, B, Heard, R, Stewart, G. Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. European Journal Of Human Genetics. 2003; 11:509-515
  • Mears, D, Stewart, G, Sun, J, Woodman, K, Bourne, R, Wang, L, Sheil, A. Experience with a porcine hepatocyte-based bioartificial liver support system. Transplantation Proceedings. 2003; 35:441-442


  • Ban, M, Stewart, G, Bennetts, B, Heard, R, Simmons, R, Maranian, M, Compston, A, Sawcer, S. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes And Immunity. 2002; 3:464-469
  • Naif, H, Cunningham, A, Alali, M, Li, S, Nasr, N, Buhler, M, Schols, D, de Clercq, E, Stewart, G. A Human Immunodeficiency Virus Type 1 Isolate from an Infected Person Homozygous for CCR5/\32 Exhibits Dual Tropism by Infecting Macrophages and MT2 Cells via CXCR4. Journal Of Virology. 2002; 76:3114-3124
  • Buhler, M, Craig, M, Donaghue, K, Badhwar, P, Willis, J, Manolios, N, Tait, B, Silink, M, Bennetts, B, Stewart, G. CCR5 Genotyping in an Australian and New Zealand type 1 Diabetes Cohort. Autoimmunity. 2002; 35:457-461
  • Loblay, R, Stewart, G, Bertouch, J, Cistulli, P, Darveniza, P, Ellis, C, Gatenby, P, Gillis, D, Hickie, I, Lloyd, A, Phillips, B, Phoon, W, Rowe, K, Steven, I, Wakefield, D, Watson, D. Chronic fatigue syndrome: clinical practical guidelines - 2002. Medical Journal Of Australia . 2002; 176 (Suppl):S17-S55


  • Young, J, Ffrench, R, Clarkson, J, Stewart, G, Liang, T, Tideman, R, Packham, D, Fulcher, D, Benson, E. In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by Interleukin-12 (IL-12). Aids Research and Human Retroviruses. 2001; 87:S54-S56
  • Gala, S, Marreiros, A, Stewart, G, Williamson, P. Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03. Blood. 2001; 26:1002-1009


  • Clegg, A, Ashton, L, Biti, R, Badhwar, P, Williamson, P, Kaldor, J, Stewart, G. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1 infected long-term non-progressors. AIDS. 2000; 14:103-108
  • Huang, Q, Teutsch, S, Buhler, M, Bennetts, B, Heard, R, Manolios, N, Stewart, G. Evaluation of the Apo-1/Fas promoter Mva 1 polymorphism in multiple sclerosis. Multiple Sclerosis. 2000; 6:14 -18
  • Marks, G, Bai, J, Simpson, S, Sullivan, E, Stewart, G. Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia : reappraising the estimates of risk. American Journal of Respiratory and Critical Care Medicine. 2000; 162:1851-1854
  • Wallman, L, Stewart, G, Chapman, J, O'Connell, P, Fulcher, D. Mycophenolate mofetil for treatment of refractory lupus nephritis: four pilot cases. Australian and New Zealand Journal of Medicine. 2000; 30:712-715
  • Buhler, M, Bennetts, B, Heard, R, Stewart, G. T cell receptor B chain genotyping in Australian relapsing-remitting multiple sclerosis patients. Multiple Sclerosis. 2000; 6:140-147

Hear Professor Stewart AM discuss his research.